Empagliflozin Ammeliorates High Glucose Induced-Cardiac Dysfuntion in Human iPSC-Derived Cardiomyocytes
Kwong‐Man Ng(Guangzhou Institutes of Biomedicine and Health), Chung‐Wah Siu(Chinese University of Hong Kong)
Cited by 84
Related Papers
Short- and potential long-term adverse health outcomes of COVID-19: a rapid review
|Emerging Microbes & Infections|2020|240
2017 consensus of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation
|Journal of Arrhythmia|2017|193
Observational study on wearable biosensors and machine learning-based remote monitoring of COVID-19 patients
|Scientific Reports|2021|82
Patients Recovered From COVID-19 Show Ongoing Subclinical Myocarditis as Revealed by Cardiac Magnetic Resonance Imaging
|JACC. Cardiovascular imaging|2020|65